The nasal spray is now undergoing phase three ... In the UK, doctors have been trialling ketamine to treat depression since 2011. Dr Rupert McShane, who has led a trial in Oxford, says ketamine ...

It’s a significant finding because, to date, most studies of ketamine in depression have relied on either intravenous or intranasal administration, the latter resulting in the approval of J&J ...

Recovery Unplugged Fort Lauderdale is proud to announce the addition of Spravato® (esketamine) therapy to its comprehensive ...

WHILE KETAMINE OFTEN comes up in conversations about psychedelic medicine, technically it’s part of a class of drugs called ...

Is ketamine a breakthrough ... a variation that has been approved for severe depression. Marketed as Spravato, it’s a nasal spray. While it’s been available for three years, it’s not ...

Benefits of ketamine for depression: Ketamine has antidepressant effects that begin within hours of taking it. This is an essential advantage over most traditional antidepressants, which can take ...

Medically reviewed by Carly Snyder, MD Ketamine infusion therapy is a promising ketamine treatment that helps certain mental ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...

Ketamine for Depression and Suicidal Thoughts ... 70 percent of patients with treatment-resistant depression who received intranasal esketamine combined with an oral antidepressant showed improvement.

Attempts to use intranasal racemic ketamine for suicidal depression have failed. The Company has formed data-sharing partnerships to license clinical trial data from a French Government-funded ...

Although the FDA has approved ketamine for use as an anesthetic, infusion therapy hasn't been approved to treat chronic pain, depression, or other conditions.